Pharmacy students' ability to identify potential drug-drug interactions

American Journal of Pharmaceutical Education

Volumn 73, Issue 2, 2009, Pages

  Saverno, Kim R ^a   Malone, Daniel C ^a,b   Kurowsky, John ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b NONE   (United States)

Author keywords

Drug interaction

Indexed keywords

ALENDRONIC ACID; AMIODARONE; BROMOCRIPTINE; CIMETIDINE; CIPROFLOXACIN; CONJUGATED ESTROGEN; DIHYDROERGOTAMINE MESILATE; FEXOFENADINE; FLUOXETINE; GLIBENCLAMIDE; IBUPROFEN; ISOSORBIDE MONONITRATE; ITRACONAZOLE; KETOCONAZOLE; METFORMIN; METHYLDOPA; METOPROLOL; PHENELZINE; PHENOBARBITAL; PHENYTOIN; PIMOZIDE; PSEUDOEPHEDRINE; QUINIDINE; RALOXIFENE; SILDENAFIL; SIMVASTATIN; SUMATRIPTAN; SUMATRIPTAN SUCCINATE; THEOPHYLLINE; UNINDEXED DRUG;

ACADEMIC ACHIEVEMENT; ADULT; ARTICLE; COLLEGE STUDENT; COMPUTER PROGRAM; CURRICULUM; DRUG CROSS REACTIVITY; EDUCATIONAL MODEL; EXPERIENTIAL LEARNING; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; OUTCOME OF EDUCATION; PHARMACY STUDENT; QUESTIONNAIRE; CLINICAL COMPETENCE; COMPARATIVE STUDY; DRUG INTERACTION; EDUCATION; METHODOLOGY; STANDARD;

ADULT; CLINICAL COMPETENCE; DRUG INTERACTIONS; EDUCATIONAL MEASUREMENT; FEMALE; HUMANS; MALE; QUESTIONNAIRES; STUDENTS, PHARMACY; YOUNG ADULT;

EID: 66849097983     PISSN: 00029459     EISSN: 15536467     Source Type: Journal    
DOI: 10.5688/aj730227     Document Type: Article

References (21)

1. Juurlink DN, Mamdani M, Kopp A, et al. Drug-drug interactions among elderly patients hospitalized for drug toxicity. JAMA. 2003;289(13):1652-8.
2. Knijff-Dutmer EA, Schut GA, van de Laar MA. Concomitant coumarin-NSAID therapy and risk for bleeding. Ann Pharmacother. 2003;37(1):12-6.
3. Shad MU, Marsh C, Preskorn SH. The economic consequences of a drug-drug interaction. J Clin Psychopharmacol. 2001;21(1): 119-20.
4. Ray WA, Murray KT, Meredith S, et al. Oral erythromycin and the risk of sudden death from cardiac causes. N Engl J Med. 2004; 351(11):1089-96.
5. Jankel CA, Speedie SM. Detecting drug interactions: a review of the literature. Drug Intell Clin Pharm. 1990;24(10):982-9.
6. Chui MA RM. Evaluation of online prospective DUR programs in community pharmacy practice. J Manage Care Pharm. 2000;6: 27-32.
7. Peng CC, Glassman PA, Marks IR, et al. Retrospective drug utilization review: incidence of clinically relevant potential drug- drug interactions in a large ambulatory population. J Manage Care Pharm. 2003;9(6):513-22.
8. Abarca J, Malone DC, Armstrong EP, et al. Concordance of severity ratings provided in four drug interaction compendia. JAm Pharm Assoc. 2004;44(2):136-41.
9. Hazlet TK, Lee TA, Hansten PD, et al. Performance of community pharmacy drug interaction software. J Am Pharm Assoc. 2001; 41(2):200-4.
10. Abarca J, Colon LR, Wang VS, et al. Evaluation of the performance of drug-drug interaction screening software in community and hospital pharmacies. J Manage Care Pharm. 2006;12(5):383-9.
11. Cavuto NJ, Woosley RL, Sale M. Pharmacies and prevention of potentially fatal drug interactions. JAMA. 1996;275(14):1086-7.
12. Weideman RA, Bernstein IH, McKinney WP. Pharmacist recognition of potential drug interactions. Am J Health-Syst Pharm. 1999;56(15):1524-9.
13. Glassman PA, Belperio P, Simon B, et al. Exposure to automated drug alerts over time: effects on clinicians' knowledge and perceptions. Med Care. 2006;44(3):250-6.
14. Glassman PA, Simon B, Belperio P, et al. Improving recognition of drug interactions: benefits and barriers to using automated drug alerts. Med Care. 2002;40(12):1161-71.
15. Ko Y, Malone DC, Skrepnek GH, et al. Prescribers' Knowledge of and Sources of Information for Potential Drug-Drug Interactions: A Postal Survey of US Prescribers. Drug Safety. 2008;31(6):525-36.
16. Micromedex Healthcare Series. Thomson Healthcare. http://www.thomsonhc. com Accessed January 21, 2009.
17. Evaluations of Drug Interactions. San Bruno, CA: First DataBank, Inc, The Hearst Corporation 2006.
18. Top 200 Prescription Drugs of 2006. Pharmacy Times http:// pharmacytimes.com/Article.cfm?Menu= 1&ID=4629. Accessed January 21, 2008.
19. Malone DC, Hutchins DS, Haupert H, et al. Assessment of potential drug-drug interactions with a prescription claims database. Am J Health-Syst Pharm. 2005;62(19):1983-91.
20. Mahmood M, Malone DC, Skrepnek GH, et al. Potential drug-drug interactions within Veterans Affairs medical centers. Am J Health-Syst Pharm. 2007;64(14):1500-5.
21. Ko Y, Abarca J, Malone DC, et al. Practitioners' views on computerized drug-drug interaction alerts in the VA system. J Am Med Inform Assoc. 2007;14(1):56-64.